Syngene International Limited (SYNGENE.NS)
INR 727.0
(-0.29%)
INR 727.0
(-0.29%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 12.71 INR | 9.66% |
| 2022 | 11.59 INR | 16.6% |
| 2021 | 9.94 INR | -2.36% |
| 2020 | 10.18 INR | -1.93% |
| 2019 | 10.38 INR | 23.87% |
| 2018 | 8.38 INR | 8.27% |
| 2017 | 7.74 INR | 5.16% |
| 2016 | 7.36 INR | 18.9% |
| 2015 | 6.19 INR | 34.57% |
| 2014 | 4.60 INR | 27.78% |
| 2013 | 3.60 INR | 22.03% |
| 2012 | 2.95 INR | 40.48% |
| 2011 | 2.10 INR | 159.26% |
| 2010 | 0.81 INR | -10.0% |
| 2009 | 0.90 INR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 1.88 INR | -60.0% |
| 2024 Q2 | 2.64 INR | 40.43% |
| 2023 Q4 | 4.70 INR | 68.46% |
| 2023 Q3 | 2.79 INR | -4.12% |
| 2023 FY | - INR | 9.66% |
| 2023 Q1 | 2.33 INR | -47.87% |
| 2023 Q2 | 2.91 INR | 24.89% |
| 2022 FY | - INR | 16.6% |
| 2022 Q2 | 2.55 INR | 37.84% |
| 2022 Q3 | 2.74 INR | 7.45% |
| 2022 Q1 | 1.85 INR | -52.81% |
| 2022 Q4 | 4.47 INR | 63.14% |
| 2021 Q3 | 2.57 INR | 56.71% |
| 2021 Q4 | 3.92 INR | 52.53% |
| 2021 FY | - INR | -2.36% |
| 2021 Q1 | 1.91 INR | -52.72% |
| 2021 Q2 | 1.64 INR | -14.14% |
| 2020 Q4 | 4.04 INR | 57.2% |
| 2020 Q1 | 1.47 INR | -51.49% |
| 2020 FY | - INR | -1.93% |
| 2020 Q2 | 2.12 INR | 44.22% |
| 2020 Q3 | 2.57 INR | 21.23% |
| 2019 Q1 | 1.47 INR | -41.67% |
| 2019 Q2 | 3.23 INR | 119.73% |
| 2019 Q4 | 3.03 INR | 30.6% |
| 2019 Q3 | 2.32 INR | -28.17% |
| 2019 FY | - INR | 23.87% |
| 2018 Q3 | 2.19 INR | 10.61% |
| 2018 Q2 | 1.98 INR | 18.56% |
| 2018 Q1 | 1.67 INR | -21.6% |
| 2018 Q4 | 2.52 INR | 15.07% |
| 2018 FY | - INR | 8.27% |
| 2017 Q2 | 1.94 INR | 22.78% |
| 2017 Q4 | 2.13 INR | 2.9% |
| 2017 Q1 | 1.58 INR | -21.0% |
| 2017 FY | - INR | 5.16% |
| 2017 Q3 | 2.07 INR | 6.7% |
| 2016 Q1 | 1.54 INR | -24.51% |
| 2016 Q4 | 2.00 INR | 5.26% |
| 2016 Q3 | 1.90 INR | -0.52% |
| 2016 Q2 | 1.91 INR | 24.03% |
| 2016 FY | - INR | 18.9% |
| 2015 Q1 | 1.21 INR | -13.57% |
| 2015 FY | - INR | 34.57% |
| 2015 Q4 | 2.04 INR | 18.6% |
| 2015 Q3 | 1.72 INR | 37.6% |
| 2015 Q2 | 1.25 INR | 3.31% |
| 2014 FY | - INR | 27.78% |
| 2014 Q4 | 1.40 INR | 20.69% |
| 2014 Q1 | 0.96 INR | 0.0% |
| 2014 Q2 | 1.07 INR | 11.46% |
| 2014 Q3 | 1.16 INR | 8.41% |
| 2013 FY | - INR | 22.03% |
| 2012 FY | - INR | 40.48% |
| 2011 FY | - INR | 159.26% |
| 2010 FY | - INR | -10.0% |
| 2009 FY | - INR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Biocon Limited | 8.55 INR | -48.655% |
| Blue Jet Healthcare Limited | 9.44 INR | -34.64% |
| Concord Biotech Limited | 29.45 INR | 56.842% |
| Dishman Carbogen Amcis Limited | -9.79 INR | 229.826% |
| Jubilant Ingrevia Limited | 11.56 INR | -9.948% |
| Lyka Labs Limited | -0.75 INR | 1794.667% |
| Panacea Biotec Limited | -0.19 INR | 6789.474% |
| Piramal Pharma Limited | 0.14 INR | -8978.571% |
| SMS Lifesciences India Limited | 30.08 INR | 57.746% |
| Supriya Lifescience Limited | 14.80 INR | 14.122% |
| TAKE Solutions Limited | -8.18 INR | 255.379% |
| Zota Health Care Limited | -5.55 INR | 329.009% |